Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01102114 · ClinicalTrials.gov registry record · Phase 3
A Second Study of NicVAX/Placebo as an Aid for Smoking Cessation
A Phase 3 study, sponsored by Nabi Biopharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,000
- Enrollment target
NCT01102114: Completed Phase 3 study, sponsored by Nabi Biopharmaceuticals.
NCT01102114 is a Phase 3 study that has completed, run by Nabi Biopharmaceuticals. The registered enrollment target is 1,000 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (30% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01102114, a Phase 3 study, has completed, sponsored by Nabi Biopharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,000 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate NicVAX as an aid to smoking cessation for long term abstinence.
Interventions
- BIOLOGICAL Placebo Vaccine
- BIOLOGICAL NicVAX Vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2010-03 |
| Est. Completion | 2011-11 |
| Phase | Phase 3 |
What the finished NCT01102114 record still lists
NCT01102114 is an interventional study that assigns participants to a tested intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (30% higher).
The record links to 0 conditions, and to 2 interventions - of which Placebo Vaccine is the first listed.
NCT01102114 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01102114 about?
NCT01102114 is a clinical study titled "A Second Study of NicVAX/Placebo as an Aid for Smoking Cessation". The purpose of this study is to evaluate NicVAX as an aid to smoking cessation for long term abstinence.
What is the current status of trial NCT01102114?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,000 participants. The study started on 2010-03. Estimated completion is 2011-11.
What interventions are being tested in trial NCT01102114?
The interventions under investigation include: Placebo Vaccine (BIOLOGICAL), NicVAX Vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT01102114?
This trial is sponsored by Nabi Biopharmaceuticals, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01102114's enrollment target sits among peer trials
1,000 296th of 2000 higher than 1,689 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia